TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 17544379

Group type: EXPERIMENTAL
Intervention: Acute tryptophan depletion (ATD) in women
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: Acute tryptophan depletion (ATD) in men
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: 5-HTTLPR influence in women during ATD
Number of subjects: 83
Study: 15363069

Group type: EXPERIMENTAL
Intervention: EP-guided therapy
Number of subjects: 100
Study: 11432797

Group type: EXPERIMENTAL
Intervention: Initial daily dosing of 6 MU Interferon-alpha-2a daily for 12 weeks, then reduced to 6 MU three times weekly until week 12 and 3 MU three times weekly thereafter until month 12.
Number of subjects: 64

Group type: COMPARATOR
Intervention: Standard therapy with 5 MU Interferon-alpha-2b or 6 MU Interferon-alpha-2a three times a week for 12 months.
Number of subjects: 64
Study: 9730559

Group type: EXPERIMENTAL
Intervention: Ganciclovir treatment
Number of subjects: 153

Group type: COMPARATOR
Intervention: Ganciclovir untreated (OKT3 group)
Number of subjects: 153

Group type: COMPARATOR
Intervention: Ganciclovir untreated (methylprednisolone group)
Number of subjects: 153

Group type: COMPARATOR
Intervention: Ciclosporin A treated group
Number of subjects: 153

Group type: COMPARATOR
Intervention: Low-grade CMV infection (no treatment)
Number of subjects: 153
Study: 7982253

Group type: EXPERIMENTAL
Intervention: Brodimoprim 200 mg tablets once a day (400 mg on the first day as a loading dose)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Cephalexin 500 mg tablets three times a day for 8 to 12 days
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Brodimoprim
Number of subjects: 49

Group type: COMPARATOR
Intervention: Cephalexin
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Brodimoprim and Cephalexin
Number of subjects: 49
Study: 2534418

Group type: EXPERIMENTAL
Intervention: Increasing left ventricular end-diastolic diameter (LVEDD)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Decreasing left ventricular end-diastolic diameter (LVEDD)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Cold pressor test
Number of subjects: 18
Study: 808445

Group type: EXPERIMENTAL
Intervention: Topical disodium cromoglycate (DSCG) 200 mg by enema twice daily and 100 mg orally three times daily
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 31953524

Group type: EXPERIMENTAL
Intervention: Apremilast
Number of subjects: 526
Study: 30642293

Group type: EXPERIMENTAL
Intervention: Lanreotide depot/autogel 120 mg every 4 weeks for 96 weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo every 4 weeks for 96 weeks
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lanreotide
Number of subjects: 0
Study: 27663451

Group type: EXPERIMENTAL
Intervention: Perineural dexamethasone (8 mg)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Intravenous dexamethasone (8 mg)
Number of subjects: 150
Study: 25096818

Group type: EXPERIMENTAL
Intervention: Omega-3 fatty acids (DHA and EPA) - 2 MorDHA capsules per day for 14 months
Number of subjects: 104

Group type: COMPARATOR
Intervention: Placebo capsules
Number of subjects: 104
Study: 24199774

Group type: EXPERIMENTAL
Intervention: Treated tea (600 mL of oolong tea treated by three Buddhist monks)
Number of subjects: 189

Group type: COMPARATOR
Intervention: Untreated tea (600 mL of ordinary oolong tea)
Number of subjects: 189

Group type: EXPERIMENTAL
Intervention: Belief in drinking treated tea
Number of subjects: 189

Group type: COMPARATOR
Intervention: No belief in drinking treated tea
Number of subjects: 189
Study: 21593492

Group type: EXPERIMENTAL
Intervention: Daily presentation of macaroni and cheese meal for 1 week
Number of subjects: 32

Group type: COMPARATOR
Intervention: Once-weekly presentation of macaroni and cheese meal for 5 weeks
Number of subjects: 32
Study: 19500854

Group type: COMPARATOR
Intervention: Spectacles
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Spectacles with Bangerter filters
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 80
Study: 17397033

Group type: EXPERIMENTAL
Intervention: 3 years of androgen suppression therapy (AST) plus external beam radiation therapy (RT)
Number of subjects: 311

Group type: COMPARATOR
Intervention: 6 months of androgen suppression therapy (AST) plus external beam radiation therapy (RT)
Number of subjects: 311
Study: 12547878

Group type: EXPERIMENTAL
Intervention: Maggot therapy
Number of subjects: 18

Group type: COMPARATOR
Intervention: Conventional therapy
Number of subjects: 18
Study: 10703801

Group type: EXPERIMENTAL
Intervention: Phenobarbital (20 mg/kg)
Number of subjects: 340

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 340

Group type: EXPERIMENTAL
Intervention: Phenobarbital (20 mg/kg) plus three or more doses of diazepam
Number of subjects: 340
Study: 9352699

Group type: EXPERIMENTAL
Intervention: Tamsulosin 0.4 mg once daily
Number of subjects: 256

Group type: COMPARATOR
Intervention: Alfuzosin 2.5 mg three times daily
Number of subjects: 256
Study: 8450526

Group type: EXPERIMENTAL
Intervention: Amlodipine (5 mg once daily)
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Nifedipine retard (20 mg twice daily)
Number of subjects: 97

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 97
Study: 3767015

Group type: EXPERIMENTAL
Intervention: 7 cm wide tourniquet at 300 mm Hg
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: 7 cm wide tourniquet at 400 mm Hg
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: 5 cm wide tourniquet
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: 7 cm wide tourniquet at 260 mm Hg
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Bier blockade tourniquet (5 cm wide)
Number of subjects: 11
Study: 30464372

Group type: EXPERIMENTAL
Intervention: Core stabilization exercise (CSE)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Control group (thermal therapy)
Number of subjects: 38
Study: 27495219

Group type: EXPERIMENTAL
Intervention: Cathodal transcranial direct current stimulation of the left posterior parietal cortex
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sham transcranial direct current stimulation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Transcranial direct current stimulation of the left primary sensorimotor cortex
Number of subjects: 0
Study: 23804546

Group type: EXPERIMENTAL
Intervention: Actiponin (450 mg day(-1))
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study: 22739693

Group type: EXPERIMENTAL
Intervention: 13-valent pneumococcal conjugate vaccine (PCV13) coadministered with trivalent inactivated influenza vaccine (TIV)
Number of subjects: 1116

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1116

Group type: EXPERIMENTAL
Intervention: 13-valent pneumococcal conjugate vaccine (PCV13)
Number of subjects: 1116

Group type: EXPERIMENTAL
Intervention: Coadministration of PCV13 and TIV
Number of subjects: 1116
Study: 20447958

Group type: EXPERIMENTAL
Intervention: Damato campimetry
Number of subjects: 100

Group type: COMPARATOR
Intervention: Humphrey automated perimetry
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Damato campimetry and Humphrey automated perimetry
Number of subjects: 100
Study: 18573802

Group type: EXPERIMENTAL
Intervention: MTX (Methotrexate) + infliximab
Number of subjects: 38

Group type: COMPARATOR
Intervention: Placebo + infliximab
Number of subjects: 38
Study: 16334714

Group type: EXPERIMENTAL
Intervention: Needling at 'Sitian' points
Number of subjects: 68

Group type: COMPARATOR
Intervention: Needling at cervical Jiaji points
Number of subjects: 68
Study: 12657842

Group type: EXPERIMENTAL
Intervention: Partial carbon dioxide rebreathing technique
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Controlled mechanical ventilation with low minute ventilation
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Spontaneous breathing
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Controlled mechanical ventilation with large tidal volume
Number of subjects: 25
Study: 10376904

Group type: EXPERIMENTAL
Intervention: IV administration of metformin (25 mg/kg)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Oral administration of metformin (25 mg/kg)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Computer simulations of oral metformin (2 mg/kg every 12 hours)
Number of subjects: 6
Study: 8901787

Group type: EXPERIMENTAL
Intervention: Iron supplementation (15 mg/d) for 3 months
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo group
Number of subjects: 0
Study: 1859009

Group type: EXPERIMENTAL
Intervention: Clonidine 5 micrograms.kg‐1
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Clonidine 2.5 micrograms.kg‐1
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Clonidine 1.2 micrograms.kg‐1
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control (no medication)
Number of subjects: 80
Study: 6181653

Group type: EXPERIMENTAL
Intervention: 600 mg femoxetine daily for 6 weeks
Number of subjects: 42

Group type: COMPARATOR
Intervention: 150 mg desipramine daily for 6 weeks
Number of subjects: 42
Study: 31026713

Group type: EXPERIMENTAL
Intervention: Enhanced training (10 hours plus ongoing coaching)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Basic training (2 hours)
Number of subjects: 60
Study: 29326015

Group type: EXPERIMENTAL
Intervention: Subcutaneous enoxaparin administered in the abdomen
Number of subjects: 301

Group type: COMPARATOR
Intervention: Subcutaneous enoxaparin administered in the arm
Number of subjects: 301
Study: 27221026

Group type: EXPERIMENTAL
Intervention: Balloon Eustachian tuboplasty (BET) only
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Balloon Eustachian tuboplasty (BET) + tympanic paracentesis (TP)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Tympanic paracentesis (TP) only
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Balloon Eustachian tuboplasty (BET) and BET + tympanic paracentesis (TP)
Number of subjects: 90
Study: 25082304

Group type: EXPERIMENTAL
Intervention: Benefits counseling (4 sessions)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Control condition (orientation to the U.S Department of Veterans Affairs health care system and services)
Number of subjects: 84
Study: 22741618

Group type: EXPERIMENTAL
Intervention: Artemisinin-piperaquine (Artequick®) - 2.8 mg/kg artemisinin plus 17.1 mg/kg piperaquine per day for 2 days
Number of subjects: 128

Group type: COMPARATOR
Intervention: Artesunate-amodiaquine (Coarsucam™) - 4.7 mg/kg artesunate plus 12.6 mg/kg amodiaquine per day for 3 days
Number of subjects: 128
Study: 20219120

Group type: EXPERIMENTAL
Intervention: Normal instructions from the supplier combined with training in the use of CCTVs
Number of subjects: 122

Group type: COMPARATOR
Intervention: Instructions from the supplier only
Number of subjects: 122
Study: 17459695

Group type: EXPERIMENTAL
Intervention: Ketorolac 15 mg i.v. bolus 20 min before induction, followed by an infusion of 7.5 mg/h
Number of subjects: 90

Group type: COMPARATOR
Intervention: Saline placebo
Number of subjects: 90
Study: 16089136

Group type: EXPERIMENTAL
Intervention: tongjingning granule (TJN)
Number of subjects: 120

Group type: COMPARATOR
Intervention: aspirin
Number of subjects: 120
Study: 12608518

Group type: EXPERIMENTAL
Intervention: I-Visc Phaco
Number of subjects: 96

Group type: COMPARATOR
Intervention: Healon5
Number of subjects: 96
Study: 10095154

Group type: EXPERIMENTAL
Intervention: Octreotide 100 microgram subcutaneously
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Octreotide 200 microgram subcutaneously
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Octreotide 100 microgram intravenously (bolus)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Octreotide 25 microgram/h intravenously (continuous infusion)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Octreotide 100 microgram/h intravenously (continuous infusion)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 8690630

Group type: EXPERIMENTAL
Intervention: Radiation therapy at 4 months after surgery for pre/perimenopausal patients
Number of subjects: 718

Group type: EXPERIMENTAL
Intervention: Radiation therapy at 7 months after surgery for pre/perimenopausal patients
Number of subjects: 718

Group type: EXPERIMENTAL
Intervention: Radiation therapy at 2 months after surgery for postmenopausal patients
Number of subjects: 718

Group type: EXPERIMENTAL
Intervention: Radiation therapy at 4 months after surgery for postmenopausal patients
Number of subjects: 718

Group type: EXPERIMENTAL
Intervention: Radiation therapy after three or six cycles of CMF for pre/perimenopausal women
Number of subjects: 718

Group type: EXPERIMENTAL
Intervention: Radiation therapy after no cycles or three cycles of CMF for postmenopausal women
Number of subjects: 718

Group type: COMPARATOR
Intervention: Radiation therapy
Number of subjects: 718
Study: 1751562

Group type: EXPERIMENTAL
Intervention: Iotrolan-300
Number of subjects: 50

Group type: COMPARATOR
Intervention: Iopamidol-300
Number of subjects: 50
Study: 6814984

Group type: EXPERIMENTAL
Intervention: Etidronate disodium (EHDP)
Number of subjects: 26
Study: 31652220

Group type: EXPERIMENTAL
Intervention: Red LED photomodulation (633 nm) for 20 minutes at 4 weekly sessions (105 mW/cm, 126 J/cm)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Red LED photomodulation (633 nm)
Number of subjects: 14
Study: 30946268

Group type: EXPERIMENTAL
Intervention: Plyometric Training (PT)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Active Control (CG)
Number of subjects: 21
Study: 28784510

Group type: EXPERIMENTAL
Intervention: Synbiotic beverage (150mL daily)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Placebo beverage (150mL daily)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Synbiotic beverage
Number of subjects: 29

Group type: COMPARATOR
Intervention: Placebo beverage
Number of subjects: 29
Study: 25660828

Group type: EXPERIMENTAL
Intervention: Wearable pulsed electromagnetic field (PEMF) therapy device
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo (disabled PEMF device)
Number of subjects: 120

Group type: COMPARATOR
Intervention: No device (control group)
Number of subjects: 120
Study: 23954024

Group type: EXPERIMENTAL
Intervention: Self-managed loaded exercise
Number of subjects: 24

Group type: COMPARATOR
Intervention: Usual physiotherapy treatment
Number of subjects: 24

Group type: COMPARATOR
Intervention: Comparison of SPADI scores
Number of subjects: 24
Study: 22179446

Group type: EXPERIMENTAL
Intervention: 3D HD video system
Number of subjects: 30

Group type: COMPARATOR
Intervention: 2D HD video system
Number of subjects: 30
Study: 19775034

Group type: EXPERIMENTAL
Intervention: Opioid-sparing postoperative analgesia protocol (tramadol patient‐controlled analgesia, parecoxib and rescue‐only morphine)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Standard morphine patient‐controlled analgesia
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Opioid-sparing postoperative analgesia protocol
Number of subjects: 62
Study: 17288687

Group type: EXPERIMENTAL
Intervention: EPs 7630 solution (30 drops three times daily for 7 days)
Number of subjects: 217

Group type: COMPARATOR
Intervention: Placebo (30 drops three times daily for 7 days)
Number of subjects: 217

Group type: EXPERIMENTAL
Intervention: EPs 7630 solution
Number of subjects: 217
Study: 11092154

Group type: EXPERIMENTAL
Intervention: Two-hour information and motivation session plus mailed personal feedback on drinking
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Mailed feedback only
Number of subjects: 37

Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 37
Study: 8819128

Group type: EXPERIMENTAL
Intervention: Intralesional GM-CSF (15-50 mg doses)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Intralesional GM-CSF
Number of subjects: 13
Study: 1453404

Group type: EXPERIMENTAL
Intervention: Extraovular intrauterine contraction monitoring
Number of subjects: 64

Group type: COMPARATOR
Intervention: Intraovular intrauterine contraction monitoring
Number of subjects: 64
Study: 3881947

Group type: EXPERIMENTAL
Intervention: Aztreonam
Number of subjects: 40

Group type: COMPARATOR
Intervention: Tobramycin
Number of subjects: 40
Study: 31599729

Group type: EXPERIMENTAL
Intervention: Smart mobile health (mHealth) tool
Number of subjects: 87

Group type: COMPARATOR
Intervention: Paper action plan
Number of subjects: 87
Study: 29716553

Group type: EXPERIMENTAL
Intervention: Preschool-based capacity building intervention
Number of subjects: 34

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 34
Study: 30230765

Group type: EXPERIMENTAL
Intervention: Nitazoxanide (NTZ)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study: 24589725

Group type: EXPERIMENTAL
Intervention: HIV-Care-Program (counseling lessons for 6 months on nutrition, hygiene, coping with stigma and discrimination)
Number of subjects: 201

Group type: COMPARATOR
Intervention: Usual-Care (control group)
Number of subjects: 201

Group type: EXPERIMENTAL
Intervention: HIV-Care-Program
Number of subjects: 201
Study: 22643234

Group type: EXPERIMENTAL
Intervention: Audiovisual (AV) stimuli presented peripherally to young participants
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Audiovisual (AV) stimuli presented peripherally to elderly participants
Number of subjects: 0
Study: 20041960

Group type: EXPERIMENTAL
Intervention: Nocturnal hemodialysis (NHD) 5 to 6 nights per week for 6 to 10 hours per night
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional hemodialysis (CvHD) thrice weekly for 6 months
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nocturnal hemodialysis (NHD)
Number of subjects: 0
Study: 16899377

Group type: EXPERIMENTAL
Intervention: Words presented in the colour they were most often presented in (75% of the time)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Words presented in the colour they were most often presented in (50% of the time)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Contingency-unaware participants
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Contingency effect
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Behavioural control
Number of subjects: 0
Study: 15661451

Group type: EXPERIMENTAL
Intervention: High TSH values (TSH >= 10 mU/L)
Number of subjects: 64887

Group type: COMPARATOR
Intervention: Normal TSH values (0.2-4 mU/L)
Number of subjects: 64887
Study: 12067084

Group type: EXPERIMENTAL
Intervention: Real acupuncture treatment (three times per week for four weeks)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Sham acupuncture treatment (three times per week for four weeks)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Real acupuncture treatment
Number of subjects: 30

Group type: COMPARATOR
Intervention: Sham acupuncture treatment
Number of subjects: 30
Study: 15321137

Group type: EXPERIMENTAL
Intervention: Bupivacaine 2.5 mg/ml (group B)
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Bupivacaine 0.625 mg/ml + sufentanil 1 microg/ml (group BS)
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Bupivacaine 0.625 mg/ml + sufentanil 1 microg/ml + epinephrine 1 microg/ml (group BSE)
Number of subjects: 140

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 140
Study: 7734157

Group type: EXPERIMENTAL
Intervention: Ciprofloxacin 500 mg orally twice a day (Group A)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ciprofloxacin drops in saline solution locally twice a day (Group B)
Number of subjects: 0
Study: 2291745

Group type: EXPERIMENTAL
Intervention: Test preparation (P)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control preparation (R)
Number of subjects: 20
Study: 30821548

Group type: EXPERIMENTAL
Intervention: Clobetasol propionate
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Petrolatum jelly
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Controlled release skin barrier emulsion
Number of subjects: 30
Study: 30849105

Group type: EXPERIMENTAL
Intervention: Core training (CT) - 3 extra sessions per week for 8 weeks
Number of subjects: 21

Group type: COMPARATOR
Intervention: Control group (CON) - maintained regular training
Number of subjects: 21
Study: 27841726

Group type: EXPERIMENTAL
Intervention: Home-based intervention (HBI)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Specialist clinic-based intervention (CBI)
Number of subjects: 100
Study: 25409100

Group type: EXPERIMENTAL
Intervention: Rapid Eye Movement (REM) sleep
Number of subjects: 58

Group type: COMPARATOR
Intervention: Non-Rapid Eye Movement (NREM) sleep
Number of subjects: 58

Group type: COMPARATOR
Intervention: Awake (WAKE)
Number of subjects: 58
Study: 22361008

Group type: EXPERIMENTAL
Intervention: Proactive intervention with four telephone supporting sessions (weeks 3, 6, 9, and 12)
Number of subjects: 626

Group type: COMPARATOR
Intervention: Control group with two check calls (weeks 3 and 12)
Number of subjects: 626

Group type: EXPERIMENTAL
Intervention: Proactive intervention group
Number of subjects: 626

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 626
Study: 21594215

Group type: EXPERIMENTAL
Intervention: 1-stage early loaded implants
Number of subjects: 47

Group type: COMPARATOR
Intervention: 2-stage early loaded implants
Number of subjects: 47
Study: 20715726

Group type: EXPERIMENTAL
Intervention: Rapid infusion of lactated Ringer's solution (20 ml.kg(‐1), n=40)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: 4% succinylated gelatin solution (500 ml, n=40)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Ephedrine infusion (1.25 mg.minute(‐1)) plus lactated Ringer's solution (1000 ml, n=40)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Crystalloid preload
Number of subjects: 120

Group type: COMPARATOR
Intervention: Colloid preload
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Ephedrine infusion with crystalloid co-load
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 120
Study: 17396039

Group type: EXPERIMENTAL
Intervention: irinotecan 80 mg/m2 followed by FA 500 mg/m2 and 5-FU 2,000 mg/m2 24 h weekly for 6 weeks
Number of subjects: 55

Group type: COMPARATOR
Intervention: irinotecan 125 mg/m2 weekly for 4 weeks
Number of subjects: 55
Study: 16391436

Group type: EXPERIMENTAL
Intervention: Famotidine
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: TIL positive patients
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: TIL negative patients
Number of subjects: 45
Study: 11952192

Group type: EXPERIMENTAL
Intervention: Behavioral couples therapy (BCT; n = 37)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Individual-based treatment (IBT; n = 38)
Number of subjects: 75
Study: 9892499

Group type: EXPERIMENTAL
Intervention: Patients with cutaneous leishmaniasis (CL)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control subjects
Number of subjects: 0